+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Breath Biopsies: A Revolutionary Approach for Noninvasive Diagnosis

  • ID: 4855529
  • Report
  • September 2019
  • Region: Global
  • 19 Pages
  • BCC Research
1 of 4

FEATURED COMPANIES

  • Algernon Pharmaceuticals
  • Bedfont Scientific
  • Breath Diagnostics
  • Cairn Diagnostics
  • Circassia
  • Ekips Technologies
  • MORE

Report Includes:

  • Detailed discussion on the breath as a snapshot of an individuals’ health
  • Assessment of the role of breath biopsy in drug development, diagnosis, and treatment of respiratory diseases, cancer, metabolic disorders, and CNS diseases
  • Discussion about proton-transfer-reaction time-of-flight mass spectrometry (PTR-ToF-MS), gas chromatography time-of-flight mass spectrometers (GC-TOF-MS) and field asymmetric ion mobility spectrometry (FAIMS)
  • Coverage of latest developments in-breath biopsy research & analysis and strategies adopted by institutes and start-up companies to identify and enhance breath biopsy in drug development

Summary

In the future, a variety of conditions may be diagnosed with a simple breath test. Researchers are looking beyond blood tests and solid/liquid biopsies to find other sources of information to diagnose disease. Every time an individual breathes, thousands of volatile organic compounds (VOCs) and volatile fatty acids (VFAs), the breakdown products of lipids and proteins,1 are released into the breath. These novel biomarkers are by-products of metabolism, and can provide a snapshot of an individual’s health.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Algernon Pharmaceuticals
  • Bedfont Scientific
  • Breath Diagnostics
  • Cairn Diagnostics
  • Circassia
  • Ekips Technologies
  • MORE

Chapter 1 Monitoring Volatile Organic Compounds

  • Introduction
  • Analyst's Credentials
  • Custom Research
  • Related Reports

Chapter 2 Value Proposition of Breath Testing

  • Value Proposition of Breath Testing
  • Technological Advances in Analytical Techniques
  • Technological Advances in Breath Collection

Chapter 3 Applications in Diagnostics

  • Identifying Food Intolerances
  • Guiding Asthma Treatment Decisions
  • Early Detection of Gastroesophageal and Lung Cancer
  • Diagnosing of Liver Disease and Personalizing Treatment
  • Breath Biopsy Could Revolutionize MS Diagnosis
  • Challenges for the Future Development of Breath Biopsies
  • The Future for Breath Biopsies

Chapter 4 Companies and Technologies for Which to Watch Out

  • Algernon Pharmaceuticals
  • Bedfont Scientific Breath Analyzers
  • Breath Diagnostics OneBreath Test
  • Cairn Diagnostics' 13C-Spirulina GEBT
  • Circassia's NIOX range
  • Ekips Technologies Breathmeter
  • Exalenz Biosciences' BreathID Systems
  • Menssana Research's BreathLink
  • Metabolic Solutions Gut-Chek
  • New England Breath Technologies Glucair
  • Owlstone Medical's ReCIVA

Chapter 5 References

List of Tables
Table 1: Breathe Biopsies, Biomarkers and Applications
Table 2: Approved FeNO Breath Tests
Table 3: Breath Tests
Table 4: Comparison of the Characteristics Available for Breath Analysis
Table 5: Advances in Gas Phase Analytical Techniques
Table 6: Companies Leading the Field in Breath Testing Technologies

List of Figures
Figure 1: VOC Analysis
Figure 2: Breathtec Device, Owlstone’s ReCIVA Breath Sampler

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Algernon Pharmaceuticals
  • Bedfont Scientific
  • Breath Diagnostics
  • Cairn Diagnostics
  • Circassia
  • Ekips Technologies
  • Exalenz Biosciences
  • Menssana Research
  • Metabolic Solutions
  • New England Breath Technologies
  • Owlstone Medical
Note: Product cover images may vary from those shown
Adroll
adroll